Blurbs

Analysts Offer Insights on Healthcare Companies: Prothena (PRTA), Crispr Therapeutics AG (CRSP) and SI-Bone (SIBN)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Prothena (PRTAResearch Report), Crispr Therapeutics AG (CRSPResearch Report) and SI-Bone (SIBNResearch Report) with bullish sentiments.

Prothena (PRTA)

JMP Securities analyst Jason Butler reiterated a Buy rating on Prothena today and set a price target of $50.00. The company’s shares closed last Monday at $33.01.

According to TipRanks.com, Butler ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -4.9% and a 41.4% success rate. Butler covers the Healthcare sector, focusing on stocks such as Applied Molecular Transport, Aquestive Therapeutics, and ACADIA Pharmaceuticals.

Prothena has an analyst consensus of Moderate Buy, with a price target consensus of $47.50.

See today’s best-performing stocks on TipRanks >>

Crispr Therapeutics AG (CRSP)

JMP Securities analyst Silvan Tuerkcan maintained a Buy rating on Crispr Therapeutics AG today and set a price target of $100.00. The company’s shares closed last Monday at $81.39.

According to TipRanks.com, Tuerkcan is a 3-star analyst with an average return of 2.9% and a 42.7% success rate. Tuerkcan covers the Healthcare sector, focusing on stocks such as Turning Point Therapeutics, Logicbio Therapeutics, and Taysha Gene Therapies.

Crispr Therapeutics AG has an analyst consensus of Moderate Buy, with a price target consensus of $100.63, a 24.2% upside from current levels. In a report released yesterday, Brookline Capital Markets also maintained a Buy rating on the stock with a $143.00 price target.

SI-Bone (SIBN)

In a report released today, David Turkaly from JMP Securities reiterated a Buy rating on SI-Bone, with a price target of $36.00. The company’s shares closed last Monday at $16.54.

According to TipRanks.com, Turkaly is a 4-star analyst with an average return of 6.4% and a 50.7% success rate. Turkaly covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Integra Lifesciences, and OrthoPediatrics.

Currently, the analyst consensus on SI-Bone is a Strong Buy with an average price target of $24.80.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on PRTA:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos